Advisory · Metabolic / Obesity
The GLP-1 wave has reset deal benchmarks across the entire TA.
Ambrosia provides senior-led advisory for metabolic / obesity licensing, M&A, and strategic partnerships — backed by a proprietary database of 200 verified metabolic / obesity transactions.
Deal Landscape
What metabolic / obesity transactions actually look like.
Verified Transactions
200
Median Upfront
$75M
Key Structure Insight
GLP-1 programs command 2x premiums; non-GLP-1 metabolic is comparatively undervalued
Selected Work
Metabolic / Obesity·Novel metabolic mechanism — strategic positioning and counterparty mapping
Related Insights
Research relevant to metabolic / obesity.
Discuss your metabolic / obesity transaction.
We’ll meet you at peer level — anywhere in the world.